Scarica l'app Stockscreener
14.81
6.27%
-0.99
Dopo l'orario di chiusura:
14.81
Precedente Chiudi:
$15.80
Aprire:
$15
Volume 24 ore:
172.61K
Relative Volume:
0.69
Capitalizzazione di mercato:
$1.91B
Reddito:
$65.48M
Utile/perdita netta:
$-94.46M
Rapporto P/E:
-20.08
EPS:
-0.7375
Flusso di cassa netto:
$-71.18M
1 W Prestazione:
-0.34%
1M Prestazione:
+2.07%
6M Prestazione:
-12.98%
1 anno Prestazione:
+25.30%
Intervallo 1D:
$14.74
$15.27
Intervallo di 1 settimana:
$14.26
$16.50
Portata 52W:
$9.61
$21.50
Mesoblast Ltd Adr Stock (MESO) Company Profile
Nome
Mesoblast Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare MESO vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MESO
Mesoblast Ltd Adr
|
14.81 | 1.91B | 65.48M | -94.46M | -71.18M | -0.7375 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Mesoblast Ltd Adr Stock (MESO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-07-18 | Downgrade | Jefferies | Buy → Hold |
| 2024-12-23 | Downgrade | Jefferies | Buy → Hold |
| 2024-09-24 | Aggiornamento | Maxim Group | Hold → Buy |
| 2024-08-29 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-23 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-08-31 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-07 | Downgrade | Maxim Group | Buy → Hold |
| 2023-08-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-08-04 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-03-09 | Iniziato | William Blair | Outperform |
| 2022-12-06 | Downgrade | Jefferies | Buy → Hold |
| 2022-09-06 | Iniziato | Piper Sandler | Overweight |
| 2021-04-07 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-12-22 | Downgrade | Maxim Group | Buy → Hold |
| 2020-12-04 | Downgrade | Chardan Capital Markets | Neutral → Sell |
| 2020-10-22 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-08-14 | Reiterato | Maxim Group | Buy |
| 2020-05-28 | Reiterato | H.C. Wainwright | Buy |
| 2019-01-31 | Ripresa | H.C. Wainwright | Buy |
| 2018-03-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2018-02-28 | Reiterato | Cantor Fitzgerald | Buy |
| 2017-08-31 | Iniziato | Oppenheimer | Outperform |
| 2017-06-08 | Iniziato | Cantor Fitzgerald | Buy |
Mostra tutto
Mesoblast Ltd Adr Borsa (MESO) Ultime notizie
MESO Ignites 10% Surge: A Biotech Spark Ignited Without a Visible Fuse - Bitget
Philip Krause details Mesoblast (NASDAQ: MESO) share and option holdings - Stock Titan
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. - Benzinga
Mesoblast issues 5 million unquoted warrants as fee for US$50 million convertible note facility - MSN
Mesoblast Ltd Stock (ISIN: AU000000MSB8) Faces Pressure as Director Buys Signal Confidence Amid Anal - AD HOC NEWS
Gregory George beneficial owner at Mesoblast (OTC: MEOBF) with 22.36% stake - Stock Titan
MEOBF SEC FilingsMesoblast 10-K, 10-Q, 8-K Forms - Stock Titan
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them - Sahm
Earnings call transcript: Mesoblast’s strong Q1 2026 performance boosts outlook - Investing.com
FARM 51 GROUP S.A.ZY -,1.XFRA: MWBMUHANDELSUNTERBRECHUNGTEIL 5 - aktiencheck.de
Mesoblast stock reaches 52-week high at 21.05 USD - Investing.com
Mesoblast stock reaches 52-week high at 21.05 USD By Investing.com - Investing.com India
Mesoblast announces board leadership changes as company evolves - Investing.com South Africa
Mesoblast Shares (ASX:MSB) Stall at Resistance After Recent Rally - thebull.com.au
ETFs Investing in Mesoblast Limited Sponsored ADR Stocks - TradingView
Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - inkl
Jefferies upgrades Mesoblast stock to Buy on strong Ryoncil sales - Investing.com
Mesoblast rides early ryoncil® momentum, tightens cash discipline, and prepares for next growth phase - Proactive financial news
Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket - Benzinga
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Mesoblast secures up to US$50m in fresh funding through convertible note agreements - Biotech Dispatch
Mesoblast Secures Up To US$50 Mln In Convertible Note Agreements With Key Investors - Nasdaq
Canaccord Genuity initiates Mesoblast stock with Buy rating on cell therapy potential - Investing.com
Mesoblast stock soars after reporting first Ryoncil sales - Investing.com
Mesoblast Targets Accelerated FDA Approval For Heart Failure Drug Revascor - Sahm
Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Benzinga
All Markets & Instruments Available to Trade - Capital.com
ASX Lunch Wrap: ASX and gold reset record highs; but Origin cuts its LNG forecast - Stockhead
Why are Mesoblast shares in a trading halt? - The Motley Fool Australia
ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead
Mesoblast After Approval: Stock Is Buoyant Now, But Unpredictable Overall (NASDAQ:MESO) - seekingalpha.com
Mesoblast Finally Gets Its Approval In GVHD: Where Now? (NASDAQ:MESO) - seekingalpha.com
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
Mesoblast: Undervalued Due To Remestemcel-L's Substantial Growth Potential (NASDAQ:MESO) - seekingalpha.com
MESOMesoblast Ltd ADR Short Interest - Finviz
Mesoblast Limited: Back From The Dead (NASDAQ:MESO) - Seeking Alpha
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Mesoblast Ltd Share Price ADR Each Representing 10 Ord Shares SPON - hl.co.uk
What is the current Price Target and Forecast for Mesoblast Limited (MESO) - Zacks Investment Research
MESO Financial Statements & ChartsMesoblast LtdAdr MacroTrends - CMLviz
MESO Pivot Points, Technical Analysis and Moving AveragesMesoblast LtdAdr Technicals - CMLviz
Maxim Group Stick to Their Buy Rating for Mesoblast Ltd - Investing.com
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod - Yahoo Finance
Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy - Novartis
How many stocks fighting COVID-19 have maintained their momentum? - Stockhead
Mesoblast Ltd Adr Azioni (MESO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):